Qianjin Pharmaceutical: Net profit of 286 million yuan in 2025, up 24.07% year-on-year

Qianjin Pharmaceutical Announcement, 2025 operating revenue is 3.63B yuan, a decrease of 0.03% year-on-year; net profit is 286 million yuan, an increase of 24.07% year-on-year. The profit distribution plan for 2025: distribute a cash dividend of 3.8 yuan (including tax) for every 10 shares to all shareholders of the company.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin